Prejex Inc., a spin-off of Germany-based Prejex GMBH, entered into an agreement with Pune India-based Polybond, of the Rathi Group, to manufacture needle-less injections.
This partnership has enabled the shifting of the manufacturing capabilities of the German company from Berlin to Pune. The Prejex-Polybond factory will make needle-less injections for global markets, said Prejex Inc.
Two different models will be launched:
- The N-Jector Series—a single-dose disposable device: Here, the dose is ‘pre-charged’ or ‘pre-filled’ in an ampoule and the device can easily be packed and disposed of once the dose has been administered. The device and/or ampoule can both be stored in a refrigerator or at room temperature.
- The Prejex Multi-Reusable Device goes up to 30,000 clicks and is ideal for home use and/or self-administration. It is compatible with pre-filled and non-filled ampoules that can be attached easily via a simple twist.
The company claimed a broad spectrum of applications for the use of these needle-less injections including Diabetes, Endocrinology, Oncology supportive care, local anesthetics, autoimmune diseases, fertility hormones, erectile dysfunction, vaccines, cosmetics, and biosimilars.
Adit Rathi, managing director, Polybond India Pvt Ltd., said, “We are proud to be associated as the manufacturing partner for needle-less injections for Prejex GmbH. This association is a true example of the ‘Make in India’ movement. Not only will European consumers get the benefit of European innovation combined by competitive Indian costs, such associations also accelerate the introduction of innovative products in the Indian market.”
Last updated: December 26th, 2025
